Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Japanese investigators discover novel antitumor/antimicrobial agent produced by actinomycete

July 29, 1999

EntreMed cleared to begin phase I trials of Endostatin protein

July 29, 1999

Irinotecan approved as first-line treatment for advanced colorectal cancer in Europe

July 29, 1999

Approval of Busulfex injection in Canada

July 29, 1999

Abbott signs paclitaxel agreement with NaPro BioTherapeutics

July 29, 1999

Novel epipodophyllotoxin derivatives with excellent antitumor activity

July 28, 1999

Asmarine A and B: novel cytotoxic alkaloids produced by marine organism

July 28, 1999

Kinetek initiates development of ILK and PKB inhibitors for cancer therapy

July 28, 1999

Bayer presents new anticancer compounds that inhibit Raf kinase

July 27, 1999

Paxene approved for E.U. marketing; Paxoral shows positive results in phase I

July 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...